REPL Competitors & Alternatives
Compare Replimune Group Inc with similar stocks in the same industry
Biotechnology
REPL
Main Stock$11.20
Tradestie Score
47
Market Cap
$328.62M
Analyst Upside
-4.8%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$82.05
|
$492.21M | - | 50 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 56 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$7.78
|
$468.01M | - | 51 | Compare |
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$16.52
|
$463.20M | - | 60 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$8.06
|
$457.09M | - | 52 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$6.57
|
$454.29M | - | 55 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 53 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$18.44
|
$448.32M | - | 56 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 58 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$28.25
|
$422.50M | - | 50 | Compare |
More REPL Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry